Growth Metrics

Erasca (ERAS) Change in Accured Expenses (2020 - 2026)

Erasca posted quarterly Change in Accured Expenses of -$3.3 million for Q1 2026, up 59.17% year-on-year from -$2.1 million in Q1 2025, and down 295.75% on a QoQ basis from $1.7 million in Q4 2025.

Erasca (ERAS) has 7 years of Change in Accured Expenses data on file, last reported at -$3.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses rose 59.17% year-over-year to -$3.3 million; the trailing twelve-month figure through Mar 2026 stood at $969000.0 (down 51.93% YoY), and the FY2025 full-year result was -$3.8 million, down 158.91% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$3.3 million, down from $1.7 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $5.5 million in Q3 2024 and bottomed at -$8.0 million in Q1 2025.
  • The 5-year median for Change in Accured Expenses is $1.3 million (2024), against an average of $122117.6.
  • The widest annual swing landed in 2022, when Change in Accured Expenses slumped 1135.69%; it then surged 240.13% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $2.1 million in 2022, then slumped by 54.27% to $952000.0 in 2023, then soared by 240.13% to $3.2 million in 2024, then tumbled by 48.42% to $1.7 million in 2025, then sank by 295.75% to -$3.3 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$3.3 million (Q1 2026), $1.7 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 931,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 70.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -176.03 Mn
10 Erasca 4.21 Bn 3.97 Bn - -3.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3.27 Mn
Mar 31, 2026 -3.27 Mn
Dec 31, 2025 1.67 Mn
Dec 31, 2025 1.67 Mn
Sep 30, 2025 1.19 Mn
Sep 30, 2025 1.19 Mn
Jun 30, 2025 1.38 Mn
Jun 30, 2025 1.38 Mn
Mar 31, 2025 -8.01 Mn
Mar 31, 2025 -8.01 Mn
Dec 31, 2024 3.24 Mn
Dec 31, 2024 3.24 Mn
Sep 30, 2024 5.47 Mn
Sep 30, 2024 5.47 Mn
Jun 30, 2024 1.31 Mn
Jun 30, 2024 1.31 Mn
Mar 31, 2024 -3.63 Mn
Mar 31, 2024 -3.63 Mn
Dec 31, 2023 952,000.00
Dec 31, 2023 952,000.00
Sep 30, 2023 2.47 Mn
Sep 30, 2023 2.47 Mn
Jun 30, 2023 -1.36 Mn
Jun 30, 2023 -1.36 Mn
Mar 31, 2023 -4.36 Mn
Mar 31, 2023 -4.36 Mn
Dec 31, 2022 2.08 Mn
Dec 31, 2022 2.08 Mn
Sep 30, 2022 3.58 Mn
Sep 30, 2022 3.58 Mn
Jun 30, 2022 3.01 Mn
Jun 30, 2022 3.01 Mn
Mar 31, 2022 -3.66 Mn
Mar 31, 2022 -3.66 Mn
Dec 31, 2021 4.69 Mn
Dec 31, 2021 4.69 Mn
Sep 30, 2021 2.19 Mn
Sep 30, 2021 2.19 Mn
Jun 30, 2021 4.63 Mn
Jun 30, 2021 4.63 Mn
Mar 31, 2021 353,000.00
Mar 31, 2021 353,000.00
Dec 31, 2020 1.25 Mn
Dec 31, 2020 1.25 Mn
Sep 30, 2020 1.99 Mn
Sep 30, 2020 1.99 Mn